ASTRAZENECA PHARMA INDIA
|
ASTRAZENECA PHARMA INDIA Last 5 Year Cashflow Statement History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹252 Cr | ₹156 Cr | ₹220 Cr | ₹134 Cr | ₹83 Cr |
| Adjustment | ₹33 Cr | ₹76 Cr | ₹-7.07 Cr | ₹-4.80 Cr | ₹9.66 Cr |
| Changes In working Capital | ₹-217 Cr | ₹-103 Cr | ₹-128 Cr | ₹-30 Cr | ₹33 Cr |
| Cash Flow after changes in Working Capital | ₹68 Cr | ₹130 Cr | ₹84 Cr | ₹99 Cr | ₹126 Cr |
| Cash Flow from Operating Activities | ₹-15 Cr | ₹65 Cr | ₹28 Cr | ₹58 Cr | ₹101 Cr |
| Cash Flow from Investing Activities | ₹19 Cr | ₹31 Cr | ₹22 Cr | ₹18 Cr | ₹4.74 Cr |
| Cash Flow from Financing Activities | ₹-92 Cr | ₹-66 Cr | ₹-44 Cr | ₹-24 Cr | ₹-9.46 Cr |
| Net Cash Inflow / Outflow | ₹-88 Cr | ₹31 Cr | ₹5.23 Cr | ₹52 Cr | ₹96 Cr |
| Opening Cash & Cash Equivalents | ₹536 Cr | ₹506 Cr | ₹500 Cr | ₹448 Cr | ₹352 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹448 Cr | ₹536 Cr | ₹506 Cr | ₹500 Cr | ₹448 Cr |
Compare Cashflow Statement of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹18,526.3 Cr | -2.9% | -5.9% | -9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -2.9% |
-5.9% |
-9.5% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses